Resona Asset Management Co. Ltd. Acquires 4,604 Shares of The Clorox Company $CLX

Resona Asset Management Co. Ltd. increased its stake in shares of The Clorox Company (NYSE:CLX) by 8.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 61,653 shares of the company’s stock after acquiring an additional 4,604 shares during the quarter. Resona Asset Management Co. Ltd. owned about 0.05% of Clorox worth $7,384,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. OneDigital Investment Advisors LLC acquired a new stake in Clorox during the first quarter worth about $247,000. Nisa Investment Advisors LLC raised its position in Clorox by 1.2% in the first quarter. Nisa Investment Advisors LLC now owns 26,650 shares of the company’s stock worth $3,924,000 after purchasing an additional 317 shares in the last quarter. Cerity Partners LLC lifted its stake in Clorox by 13.3% during the first quarter. Cerity Partners LLC now owns 63,499 shares of the company’s stock worth $9,350,000 after purchasing an additional 7,451 shares during the period. Xponance Inc. lifted its stake in Clorox by 1.9% during the first quarter. Xponance Inc. now owns 28,419 shares of the company’s stock worth $4,185,000 after purchasing an additional 530 shares during the period. Finally, Platform Technology Partners boosted its holdings in Clorox by 4.2% during the first quarter. Platform Technology Partners now owns 7,753 shares of the company’s stock valued at $1,142,000 after purchasing an additional 315 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on CLX shares. TD Cowen dropped their target price on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. Jefferies Financial Group reiterated a “buy” rating and issued a $152.00 price target on shares of Clorox in a research report on Tuesday. JPMorgan Chase & Co. cut their price objective on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. Citigroup reduced their target price on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 4th. Finally, The Goldman Sachs Group dropped their target price on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday, October 1st. One analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $125.69.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Clorox Price Performance

Shares of CLX stock opened at $107.37 on Friday. The Clorox Company has a 52 week low of $106.14 and a 52 week high of $171.37. The stock has a market capitalization of $13.10 billion, a PE ratio of 16.47, a PEG ratio of 0.92 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock’s fifty day moving average is $119.49 and its 200-day moving average is $124.82.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the company earned $1.86 EPS. The firm’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio is 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.